Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Volume 6 Issue 5, May 2024

Small vesicles as metabolic mediators

Small extracellular vesicles released from adipose tissue macrophages in mice that were treated with the anti-diabetic drug rosiglitazone improve insulin sensitivity in obese mice, circumventing the severe adverse effects of the drug. The image is an illustration of human cells secreting small extracellular vesicles.

See Rohm et al.

Credit: Image: JUAN GAERTNER/SCIENCE PHOTO LIBRARY. Cover Design: Thomas Phillips.

Comment & Opinion

  • Recent technological advances permit the profiling of metabolic changes in single cells, which sheds light on how metabolism regulates immune responses. We advocate for accessible and standardized tools to reduce the barrier of entry to immunometabolism studies and facilitate the translation of fundamental findings towards clinical applications.

    • Jason Cosgrove
    • Antoine Marçais
    • Jan Van den Bossche
    Comment

    Advertisement

Top of page ⤴

News & Views

  • In this issue of Nature Metabolism, the research team of Mitchell Lazar reveals unexpected consequences of double loss of the coregulators NCOR1 and NCOR2 (NCOR1/2) in hepatocytes of adult mice, which affects chromatin functioning and glucocorticoid receptor (GR)-mediated gene transcription.

    • Chloé Van Leene
    • Karolien De Bosscher
    News & Views
  • Thiazolidinediones (TZDs) are potent insulin-sensitizing drugs, but their use is accompanied by adverse side-effects. Rohm et al. now report that TZD-stimulated macrophages release miR-690-containing vesicles that improve insulin sensitization and bypass unwanted side-effects.

    • Rinke Stienstra
    • Eric Kalkhoven
    News & Views
  • Maternal circadian rhythms influence the health of infants. Cui, Xu and colleagues find that disruption of maternal rhythms impairs neonatal immune cell function and aggravates neonatal inflammatory disorders, which can be rescued by the administration of docosahexaenoic acid (a metabolite found in breast milk).

    • Xia Li
    • Markus Sperandio
    • Christoph Scheiermann
    News & Views
Top of page ⤴

Research Briefings

  • A new engineering strategy for improving the biosynthesis of secondary metabolites in Streptomyces has been developed through the analysis of genes co-evolved with biosynthetic gene clusters. This strategy has been verified in 11 Streptomyces strains to enhance production of 16,385 metabolites, showing potential applications in drug discovery and industrial production.

    Research Briefing
  • Agmatine produced by gut microbiota — specifically, Bacteroides vulgatus — activates the farnesoid X receptor (FXR) in intestinal epithelial L cells in a bile-acid-independent manner, which inhibits host glucagon peptide 1 (GLP-1) secretion and leads to polycystic ovary syndrome (PCOS) in mice. Supplementing mice with the GLP-1 receptor (GLP-1R) agonist liraglutide or inhibiting the production of agmatine reverses the PCOS phenotype.

    Research Briefing
Top of page ⤴

Reviews

  • Nguyen and Corvera review distinct changes that occur in adipose tissue during ageing, discuss potential mechanisms by which these changes impact whole-body metabolism, immunity and longevity, and highlight therapeutic opportunities.

    • Tammy T. Nguyen
    • Silvia Corvera
    Review Article
  • Sharma et al. review the regulation and biological functions of apparently ‘futile’ dynamic lipid cycle in regulating whole-body metabolic homeostasis.

    • Anand Kumar Sharma
    • Radhika Khandelwal
    • Christian Wolfrum
    Review Article
Top of page ⤴

Research

Top of page ⤴

Amendments & Corrections

Top of page ⤴

Search

Quick links